Mss

Edit

Oncolytics Biotech� Reports FDA Regulatory Milestone and Strong Clinical Progress in Randomized RAS-Mutant MSS Colorectal ...

Nasdaq Globe Newswire 13 Jul 2026

Oncolytics announced more than 20 patients pre-identified for REO 033 colorectal cancer trial and scheduled Type D meeting with the FDA ... .

Edit

Oncolytics Biotech® Reports FDA Regulatory Milestone and Strong Clinical Progress in Randomized RAS-Mutant MSS Colorectal Cancer Trial (Form 8-K) (Oncolytics Biotech Inc)

Public Technologies 13 Jul 2026

) Oncolytics Biotech® Reports FDA Regulatory Milestone and Strong Clinical Progress in Randomized RAS-Mutant MSS Colorectal Cancer Trial ... stable ("MSS") metastatic colorectal cancer.

Edit

Oncolytics Biotech® Reports FDA Regulatory Milestone and Strong Clinical Progress in Randomized RAS-Mutant MSS Colorectal Cancer Trial (Oncolytics Biotech Inc)

Public Technologies 13 Jul 2026

) Oncolytics Biotech® Reports FDA Regulatory Milestone and Strong Clinical Progress in Randomized RAS-Mutant MSS Colorectal Cancer Trial ... stable ("MSS") metastatic colorectal cancer.

Edit

Agenus Announces Oversubscribed Private Placement of Up to $340 Million to Advance Registrational ROBBIN Trial of Neoadjuvant BOT+BAL in MSS Colon Cancer (Form 8-K) (Agenus Inc)

Public Technologies 13 Jul 2026

Agenus Announces Oversubscribed Private Placement of Up to $340 Million to Advance Registrational ROBBIN Trial of Neoadjuvant BOT+BAL in MSS Colon Cancer • ... in microsatellite-stable (MSS) colon cancer.

Edit

Agenus Announces Oversubscribed Private Placement of Up to $340 Million to Advance Registrational ROBBIN Trial of Neoadjuvant BOT+BAL in MSS Colon Cancer (Agenus Inc)

Public Technologies 13 Jul 2026

ROBBIN is Agenus' planned randomized global Phase 3 trial evaluating neoadjuvant BOT+BAL followed by standard of care versus standard of care alone in previously untreated high-risk Stage II and Stage III MSS colon cancer.

Edit

Main thunderstorm cloud was ‘a few kilometres’ from fatal lightning strike at Pasir Ris Beach: MSS

Straits Times 09 Jul 2026

Singapore's weatherman explained the thunderstorms that left one person dead on July 5 ....

Edit

Annual Proxy Voting Report by Investment Company (Form N-PX) (MSS Series Trust)

Public Technologies 09 Jul 2026

MSS Series Trust published this content on July 09, 2026, and is solely ...

Edit

Mississippi’s educational future finds itself in capable hands

Clarionledger 07 Jul 2026

Show Caption. Hide Caption. Subscribe to the Clarion Ledger. If you are not a subscriber, consider subscribing now. You will also get access to the Clarion Ledger's E-Edition, the electronic replica of the print publication along with print archives.

Edit

Agenus Reports Landmark BOT+BAL Data Showing 33% Three-Year Overall Survival in Refractory MSS Metastatic Colorectal ...

Caledonian Record 06 Jul 2026

LEXINGTON, Mass.--(BUSINESS WIRE)--Jul 6, 2026-- ....

Edit

Maison Solutions Inc. Enters into Agreement to Divest San Gabriel and Monrovia Store Operations as ...

ACCESSWIRE 03 Jul 2026

MONTEREY PARK, CA / ACCESS Newswire / July 3, 2026 / Maison Solutions Inc. (Nasdaq.MSS) ("Maison Solutions" or the "Company"), a specialty grocery retailer offering traditional Asian food and merchandise to U.S ... About Maison Solutions Inc ... Email. ... ....

Edit

Jagannath Nayak takes over as DG Missiles & Strategic Systems (MSS) DRDO

The Hindu 30 Jun 2026

He is the chief architect of Fibre Optic Gyro (FOG) guidance for Akash missiles and DEW-based Anti-Drone systems ....

Edit

Local to Global: MSS Selects 100 Promising Micro Businesses to Lead Consumer Goods Exports (Ministry of Trade, Industry and Energy of the Republic of Korea)

Public Technologies 26 Jun 2026

). The text version of this document is not available ... Attachments Original document Permalink. Disclaimer.

Edit

Prospectus by Investment Company (Form 497) (MSS Series Trust)

Public Technologies 26 Jun 2026

). MSS Series Trust. One Rock Fund. Ticker. ONERX. Supplement dated June 26, 2026 to the Prospectus, Summary Prospectus, and ... MSS Series Trust published this content on June 26, 2026, and is solely responsible for the information contained herein ... (noodl.

Edit

Agenus Announces Three-Year Survival Data from Phase 1b BOT+BAL Study in MSS Metastatic Colorectal Cancer ...

Hastings Tribune 25 Jun 2026

LEXINGTON, Mass.--(BUSINESS WIRE)--Jun 25, 2026-- ... .

Edit

Agenus Announces Three-Year Survival Data from Phase 1b BOT+BAL Study in MSS Metastatic Colorectal Cancer to be Presented at ESMO GI 2026 (Agenus Inc)

Public Technologies 25 Jun 2026

AGEN), a leader in immuno-oncology innovation, today announced that three-year survival data from the Phase 1b C-800-01 study of botensilimab (BOT), an Fc-enhanced multifunctional anti-CTLA-4 ...

Podcasts:

Latest News for: mss

Oncolytics Biotech� Reports FDA Regulatory Milestone and Strong Clinical Progress in Randomized RAS-Mutant MSS Colorectal ...

Oncolytics Biotech® Reports FDA Regulatory Milestone and Strong Clinical Progress in Randomized RAS-Mutant MSS Colorectal Cancer Trial (Form 8-K) (Oncolytics Biotech Inc)

Oncolytics Biotech® Reports FDA Regulatory Milestone and Strong Clinical Progress in Randomized RAS-Mutant MSS Colorectal Cancer Trial (Oncolytics Biotech Inc)

Agenus Announces Oversubscribed Private Placement of Up to $340 Million to Advance Registrational ROBBIN Trial of Neoadjuvant BOT+BAL in MSS Colon Cancer (Form 8-K) (Agenus Inc)

Agenus Announces Oversubscribed Private Placement of Up to $340 Million to Advance Registrational ROBBIN Trial of Neoadjuvant BOT+BAL in MSS Colon Cancer (Agenus Inc)

Main thunderstorm cloud was ‘a few kilometres’ from fatal lightning strike at Pasir Ris Beach: MSS

Annual Proxy Voting Report by Investment Company (Form N-PX) (MSS Series Trust)

Mississippi’s educational future finds itself in capable hands

Agenus Reports Landmark BOT+BAL Data Showing 33% Three-Year Overall Survival in Refractory MSS Metastatic Colorectal ...

Maison Solutions Inc. Enters into Agreement to Divest San Gabriel and Monrovia Store Operations as ...

Jagannath Nayak takes over as DG Missiles & Strategic Systems (MSS) DRDO

Local to Global: MSS Selects 100 Promising Micro Businesses to Lead Consumer Goods Exports (Ministry of Trade, Industry and Energy of the Republic of Korea)

Prospectus by Investment Company (Form 497) (MSS Series Trust)

Agenus Announces Three-Year Survival Data from Phase 1b BOT+BAL Study in MSS Metastatic Colorectal Cancer ...

Agenus Announces Three-Year Survival Data from Phase 1b BOT+BAL Study in MSS Metastatic Colorectal Cancer to be Presented at ESMO GI 2026 (Agenus Inc)

Article Search

EXPLORE WN.com